Efficacy of Live Online Course Mindfulness Program on Perceived Fatigue in Hemodialysis Patients

NCT ID: NCT07054112

Last Updated: 2025-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-30

Study Completion Date

2027-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to assess the efficacy of a 2-month live online mindfulness meditation program in reducing perceived fatigue (measured by the SONG-HD Fatigue Scale) in patients undergoing chronic hemodialysis.

The sponsor expects that a live online mindfulness meditation course will have a significant public health impact by reducing perceived fatigue, which is strongly associated with cardiovascular events, mortality, and reduced quality of life.

Participants will be enrolled according to eligibility criteria and randomized into one of the following groups:

Experimental group: will receive an 8-week live online Mindfulness-Based Stress Reduction (MBSR) program.

Control group: will receive standard care during their hemodialysis sessions and will be offered the same live online MBSR program between months 8 and 10.

Patients will complete self-administered questionnaires at baseline, 2 months, 8 months, and 10 months to monitor changes in fatigue, anxiety, and quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic kidney disease requiring a replacement therapy is a main public health issue. The overall incidence of treated end-stage renal disease is 169 per million inhabitants in France (Annual REIN report, Biomedicine Agency, 2021). Chronic kidney disease patients requiring a replacement therapy have a very increased mortality compared to the general population and their quality of life is particularly impacted.

The international initiative Standardized Outcomes in Nephrology hemodialysis (SONG-HD) has identified and prioritized the most important outcomes for patients requiring hemodialysis. The patients, their caregivers and health professionals have highlighted that perceived fatigue is one of the biggest issues once the hemodialysis began. Fatigue is a complex and subjective experience which include physical (muscular weakness, low stamina) and psychological symptoms (feeling of increased effort and decrease cognitive endurance). For patients with chronic hemodialysis, additionally to the burden of disease, they must receive in average three dialysis sessions per week which is a source of exhaustion. Fatigue is associated with an increase of cardiovascular events, an increase of mortality, a reduction of quality of life and consequently a less good compliance to dialysis. The outcome "fatigue" is then one of the critically important outcomes which must be assessed in all clinical trials and the investigators need to explore interventions to improve well-being of patients and to prevent patient's exhaustion.

Mindfulness meditation is defined as moment to moment self-regulation of attention. This practice helps cultivate non-judgmental acceptance of the present moment. Besides, a cognitive behavioral therapy including meditation significantly improve the well-being, the mood, the anxiety and stress perception of chronic hemodialysis patients. Several studies have showed that mindfulness meditation is associated with a decrease of systolic blood pressure, a decrease of depressive symptoms and an increase in self-compassion scores in hemodialysis patients.

Numerous studies have shown a significant improvement in fatigue thanks to a mindfulness meditation program in patients with lung cancer, breast cancer, in healthcare workers facing fatigue linked to empathic distress or even in volleyball athletes presenting moral fatigue linked to strong competition. However, to our knowledge, there is no study assessing the impact of a mindfulness meditation program on fatigue patients receiving chronic hemodialysis.

The investigators hypothesize that mindfulness meditation could regulate the psychological and physical perceived fatigue of hemodialysis patients. Meditation provides techniques allowing the participant to learn to step back from emotions, thoughts and experience in general. This is the decentring process. Furthermore, yoga, which is a part of the program, can help regulate the physical aspects of fatigue by leading to an increase in muscle mass and cardiac activity.

Benefit/ risk balance Non-invasive test. Very favorable benefit/risk balance, taking into account the demonstrated benefits in terms of stress and fatigue management of mindfulness meditation programs.

Absence of serious adverse effects reported under normal conditions while respecting the usual contraindications corresponding to the inclusion criteria.

A recent research showed that practicing mindfulness meditation is associated with transient distress and negative impacts at rates similar to other psychological treatments.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Disease Requiring Hemodialysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

Patients receive an MBSR (Mindfulness on Stress Reduction) meditation program delivered by a certified instructor.

Group Type EXPERIMENTAL

Mindfulness-Based Stress Reduction (MBSR) meditation program

Intervention Type OTHER

The sessions of the meditation program (Mindfulness on Stress Reduction) will be delivered online, outside of the dialysis sessions. They will receive standard care during their hemodialysis sessions.

The program is composed of 8 sessions of 2h30 + 1 day of mindfulness, during 2 months.

Control group

Patients will be in a wait list group. They will receive their usual care during the study follow-up. Between M8 and M10 they will receive a MBSR meditation program

Group Type OTHER

Control group

Intervention Type OTHER

Patients in the control group will be in a wait list group. They will receive standard care during their hemodialysis sessions. they will receive the MBSR meditation program between M8 and M10.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mindfulness-Based Stress Reduction (MBSR) meditation program

The sessions of the meditation program (Mindfulness on Stress Reduction) will be delivered online, outside of the dialysis sessions. They will receive standard care during their hemodialysis sessions.

The program is composed of 8 sessions of 2h30 + 1 day of mindfulness, during 2 months.

Intervention Type OTHER

Control group

Patients in the control group will be in a wait list group. They will receive standard care during their hemodialysis sessions. they will receive the MBSR meditation program between M8 and M10.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>= 18 years old
* Written informed consent obtained from the participant
* Patients on chronic hemodialysis for more than 3 months
* Participant affiliated to social security system
* Internet access
* Patient motivation/commitment
* Patient having 3 days of dialysis per week

Exclusion Criteria

* Major acute depression
* Patient on peritoneal dialysis
* Already participated in an MBSR program
* Patients covered by articles L1121-5 to L1121-8 of the French Public Health Code (corresponding to protected persons: pregnant women, women who have recently given birth or are breastfeeding, persons deprived of their rights by judicial or administrative decision, minors, and persons benefiting from legal protection: curatorship or guardianship).
* Planned hospitalization within 4 months
* Known cognitive disorder (Mini Mental State Evaluation \<23 for more than 65 years)
* Known schizophrenia
* Known psychotic personality disorder
* Suicide attempt or suicidal ideation
* Addiction to alcohol or drugs during addiction treatment
* Cancer undergoing chemotherapy
* Pathological grieving process
* Compulsive eating disorders
* No understanding of French
* Unaided deafness
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Tours

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marine NAUDIN, PhD

Role: PRINCIPAL_INVESTIGATOR

CHRU de Tours

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CH Angers

Angers, , France

Site Status

CH Bayonne

Bayonne, , France

Site Status

CHRU de Bordeaux

Bordeaux, , France

Site Status

AIRBP 28

Chartres, , France

Site Status

AURAD Aquitaine

Gradignan, , France

Site Status

CHD Vendée

La Roche-sur-Yon, , France

Site Status

ECHO Nantes

Nantes, , France

Site Status

ATTIRO Orléans

Orléans, , France

Site Status

CHRU De Tours

Tours, , France

Site Status

CALYDIAL

Vienne, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marine NAUDIN, PhD

Role: CONTACT

+33 2.47.47.91.23

Bénédicte Sautenet, PU-PH

Role: CONTACT

+33 2 47 47 02 80

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Virginie BESSON

Role: primary

Pauline D'HALLUIN

Role: primary

Thomas BACHELET

Role: primary

Virginie CHAIGNE

Role: primary

Mathilde PREZEUN-REYDIT

Role: primary

Anne Hélène QUERARD

Role: primary

Lila GHOUTI

Role: primary

Alexandru GANEA

Role: primary

Nicolas GOIN

Role: primary

(+33) 2 47 47 37 39

Abdallah GUERRAOUI

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DR240292

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.